Literature DB >> 21821099

Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.

M Kvajo1, H McKellar, J A Gogos.   

Abstract

Schizophrenia is one of the most common psychiatric disorders, but despite progress in identifying the genetic factors implicated in its development, the mechanisms underlying its etiology and pathogenesis remain poorly understood. Development of mouse models is critical for expanding our understanding of the causes of schizophrenia. However, translation of disease pathology into mouse models has proven to be challenging, primarily due to the complex genetic architecture of schizophrenia and the difficulties in the re-creation of susceptibility alleles in the mouse genome. In this review we highlight current research on models of major susceptibility loci and the information accrued from their analysis. We describe and compare the different approaches that are necessitated by diverse susceptibility alleles, and discuss their advantages and drawbacks. Finally, we discuss emerging mouse models, such as second-generation pathophysiology models based on innovative approaches that are facilitated by the information gathered from the current genetic mouse models.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21821099      PMCID: PMC3351555          DOI: 10.1016/j.neuroscience.2011.07.051

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  224 in total

Review 1.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

Review 2.  Protein palmitoylation: a regulator of neuronal development and function.

Authors:  Alaa el-Din el-Husseini; David S Bredt
Journal:  Nat Rev Neurosci       Date:  2002-10       Impact factor: 34.870

3.  Investigation of white matter structure in velocardiofacial syndrome: a diffusion tensor imaging study.

Authors:  Naama Barnea-Goraly; Vinod Menon; Ben Krasnow; Alex Ko; Allan Reiss; Stephan Eliez
Journal:  Am J Psychiatry       Date:  2003-10       Impact factor: 18.112

4.  Effects of a Drd2 deletion mutation on ethanol-induced locomotor stimulation and sensitization suggest a role for epistasis.

Authors:  Abraham A Palmer; Malcolm J Low; David K Grandy; Tamara J Phillips
Journal:  Behav Genet       Date:  2003-05       Impact factor: 2.805

5.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

6.  Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit.

Authors:  David J Gerber; Diana Hall; Tsuyoshi Miyakawa; Sandra Demars; Joseph A Gogos; Maria Karayiorgou; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

7.  Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

Authors:  Ilya Chumakov; Marta Blumenfeld; Oxana Guerassimenko; Laurent Cavarec; Marta Palicio; Hadi Abderrahim; Lydie Bougueleret; Caroline Barry; Hiroaki Tanaka; Philippe La Rosa; Anne Puech; Nadia Tahri; Annick Cohen-Akenine; Sylvain Delabrosse; Sébastien Lissarrague; Françoise-Pascaline Picard; Karelle Maurice; Laurent Essioux; Philippe Millasseau; Pascale Grel; Virginie Debailleul; Anne-Marie Simon; Dominique Caterina; Isabelle Dufaure; Kattayoun Malekzadeh; Maria Belova; Jian-Jian Luan; Michel Bouillot; Jean-Luc Sambucy; Gwenael Primas; Martial Saumier; Nadia Boubkiri; Sandrine Martin-Saumier; Myriam Nasroune; Hélène Peixoto; Arnaud Delaye; Virginie Pinchot; Mariam Bastucci; Sophie Guillou; Magali Chevillon; Ricardo Sainz-Fuertes; Said Meguenni; Joan Aurich-Costa; Dorra Cherif; Anne Gimalac; Cornelia Van Duijn; Denis Gauvreau; Gail Ouellette; Isabel Fortier; John Raelson; Tatiana Sherbatich; Nadejda Riazanskaia; Evgeny Rogaev; Peter Raeymaekers; Jeroen Aerssens; Frank Konings; Walter Luyten; Fabio Macciardi; Pak C Sham; Richard E Straub; Daniel R Weinberger; Nadine Cohen; Daniel Cohen; Gail Ouelette; John Realson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-03       Impact factor: 11.205

8.  Deletion of the alpha1 or beta2 subunit of GABAA receptors reduces actions of alcohol and other drugs.

Authors:  Yuri A Blednov; S Jung; H Alva; D Wallace; T Rosahl; P-J Whiting; R Adron Harris
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

9.  The mouse VPAC2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro.

Authors:  David J Cutler; Mai Haraura; Helen E Reed; Sanbing Shen; W John Sheward; Christine F Morrison; Hugh M Marston; Anthony J Harmar; Hugh D Piggins
Journal:  Eur J Neurosci       Date:  2003-01       Impact factor: 3.386

10.  Control of synaptic strength, a novel function of Akt.

Authors:  Qinghua Wang; Lidong Liu; Lin Pei; William Ju; Gholamreza Ahmadian; Jie Lu; Yushan Wang; Fang Liu; Yu Tian Wang
Journal:  Neuron       Date:  2003-06-19       Impact factor: 17.173

View more
  20 in total

Review 1.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

2.  Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.

Authors:  Pothitos M Pitychoutis; Arnauld Belmer; Imane Moutkine; Joëlle Adrien; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

3.  Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function.

Authors:  Liana Roberts Stein; David F Wozniak; Joshua T Dearborn; Shunsuke Kubota; Rajendra S Apte; Yukitoshi Izumi; Charles F Zorumski; Shin-ichiro Imai
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 4.  Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models.

Authors:  Caitlin E McOmish; Emma L Burrows; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity.

Authors:  Daisuke Tsuboi; Keisuke Kuroda; Motoki Tanaka; Takashi Namba; Yukihiko Iizuka; Shinichiro Taya; Tomoyasu Shinoda; Takao Hikita; Shinsuke Muraoka; Michiro Iizuka; Ai Nimura; Akira Mizoguchi; Nobuyuki Shiina; Masahiro Sokabe; Hideyuki Okano; Katsuhiko Mikoshiba; Kozo Kaibuchi
Journal:  Nat Neurosci       Date:  2015-03-30       Impact factor: 24.884

Review 6.  Modeling Psychiatric Disorder Biology with Stem Cells.

Authors:  Debamitra Das; Kyra Feuer; Marah Wahbeh; Dimitrios Avramopoulos
Journal:  Curr Psychiatry Rep       Date:  2020-04-21       Impact factor: 5.285

Review 7.  Of Mice, Men, and Microbial Opsins: How Optogenetics Can Help Hone Mouse Models of Mental Illness.

Authors:  Tobias F Marton; Vikaas S Sohal
Journal:  Biol Psychiatry       Date:  2015-04-23       Impact factor: 13.382

Review 8.  Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.

Authors:  Tomás R Guilarte; Mark Opler; Mikhail Pletnikov
Journal:  Neurotoxicology       Date:  2011-12-09       Impact factor: 4.294

Review 9.  Losing your inhibition: linking cortical GABAergic interneurons to schizophrenia.

Authors:  Melis Inan; Timothy J Petros; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2012-11-29       Impact factor: 5.996

Review 10.  Recent Advances in the Genetics of Schizophrenia.

Authors:  Dimitrios Avramopoulos
Journal:  Mol Neuropsychiatry       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.